Price supervisor Stefan Meierhans has demanded that parliament vote in favour of a proposal to introduce a reference price system, which he says could save CHF400 million ($437 million) a year.
The watchdog compared the prices of 20 patent-expired active ingredients with 15 reference countries. It found the average cost of generic drugs to be 165% higher in Switzerland – and 64% more expensive for patented drugs.
It costs five times more to treat a patient with the same drug in Switzerland than in the least expensive countries of Sweden, Denmark and Britain, said Meierhans in a newsletter published on Thursday.
In May, Santésuisse and Interpharma, the umbrella organisations for Swiss insurers and pharmaceutical research companies, also criticised the high price of medicines in Switzerland.
While their report acknowledged the impact of currency exchange rates on the comparative prices, it also called on lawmakers to introduce a reference price system.
More than 20 European countries already have such a system in place that bases insurance reimbursement payments for each active ingredient on the price of the cheapest available generic.
Most Read Swiss Abroad
More
Face time: the terrifying Swiss tradition of Tschäggättä
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
This content was published on
A criminal investigation into a Swiss media editor and a former health ministry official over leaked government Covid pandemic strategy is to be closed.
‘James Bond’ Schilthorn summit re-opens in Switzerland
This content was published on
The summit of the Schilthorn mountain in Switzerland will be accessible again from Saturday after being closed for five months.
Swiss lawmakers urge tougher stance with criminal asylum seekers
This content was published on
The Swiss Senate wants to tighten laws to both restrict the movement of asylum seekers being investigated for crimes and to expel the guilty.
Switzerland eyes high-speed train fleet for European connections
This content was published on
Swiss Federal Railways eyes 40 strong high-speed train fleet to service international destinations, such as Italy and France.
This content was published on
Driven by purchases abroad, e-commerce in Switzerland continues to grow, with sales approacheing the CHF15 billion markin 2024.
Switzerland close to further restricting tobacco advertising
This content was published on
Switzerland moves a step closer to restricting tobacco advertising in the print media as one chamber of parliament votes in favour of measures.
Swiss researchers improve therapy for paralysed patients
This content was published on
Using rehabilitation robots and a spinal cord implant, Swiss researchers are helping people with spinal cord injuries to walk again.
New Swiss government minister prepared for defence mandate
This content was published on
New Swiss government minister Martin Pfister says he is prepared for the defence mandate sif he be asked to take on the vacant role.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland remains high price island for drugs
This content was published on
The price of medical drugs in Switzerland remains higher than in other major European markets, especially for generic drugs.
This content was published on
Helsana has also compiled a blacklist of expensive Swiss clinics, with the aim of rewarding clients who stay away from them. Cross-border operations are the latest money-saving strategy from Swiss insurers, eager to put the brakes on ever-increasing healthcare costs. Health costs in Switzerland increased in 2003 by more than four per cent to almost…
This content was published on
Swiss health insurance premiums are to go up again in 2021, but at 0.5% the average hike is milder than the norm over the past decades.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.